查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太地區顯影劑與注射器系統市場：分析與預測（2022-2026）
市場調查報告書
商品編碼
1415581

亞太地區顯影劑與注射器系統市場：分析與預測（2022-2026）

Asia-Pacific Contrast Media Agent and Injector System Market - Analysis and Forecast, 2022-2026
出版日期: | 出版商: BIS Research | 英文 88 Pages | 商品交期: 1-5個工作天內

價格

根據預測，亞太地區顯影劑和注射系統市場規模預計將從2022年的19.8億美元成長到2026年的26.2億美元，預測期內複合年成長率為7.24%。

該市場受到癌症和心血管疾病發病率增加等因素的推動，導致對顯影劑、注射系統和影像引導診斷的需求增加。

主要市場統計數據
預測期 2022-2026
2022年評估 19.8億美元
2026年預測 26.2億美元
複合年成長率 7.24%

由於幾個關鍵因素，亞太地區顯影劑和注射系統市場正在顯著成長。首先，癌症和心血管疾病等疾病發生率的上升增加了對顯影劑和注射系統的診斷影像的需求。這對於準確的診斷和治療計劃尤其重要。

其次，醫學影像處理技術的進步進一步推動市場成長。創新顯影劑和注射系統的開發提高了診斷程序的準確性和有效性，使醫療保健提供者更容易獲得和可靠。

最後，亞太地區醫療基礎設施的擴張和醫療支出的增加也促進了市場的擴張。隨著醫療機構不斷現代化和升級其成像能力，該地區對影像處理顯影劑和注射系統的需求預計將繼續呈上升趨勢。

本報告調查了亞太地區顯影劑和注射系統市場，並提供了市場概況、市場成長的各種影響因素分析、法律制度、專利趨勢、市場規模趨勢和預測以及主要國家的細分我們對主要企業進行了詳細的分析和總結。

市場分類

細分 1：依產品分類

  • 顯影劑
  • 注射系統

細分：噴射器系統：依產品

  • 注射器
  • 耗材及配件

細分 2：按國家/地區

  • 中國
  • 日本
  • 印度
  • 澳洲
  • 其他

目錄

執行摘要

調查範圍

調查方法

第1章 市場

  • 市場展望
  • 市場概況
  • 產業展望
    • 監管和法律要求及框架
    • 專利分析
    • 主要趨勢
  • COVID-19 對顯影劑和注射器系統市場的影響
  • 市場動態
    • 影響分析
    • 市場促進因素
    • 市場抑制因素
    • 市場機會

第2章 區域

  • 概述
  • 亞太地區
    • 主要發現
    • 市場動態
    • 市場規模/預測

第3章市場：競爭基準化分析與公司概況

  • 競爭基準化分析
    • 主要策略和發展
    • 市場佔有率分析
  • 顯影劑生態系中的活躍公司
  • 公司簡介
    • Beijing Beilu Pharmaceutical Co. Ltd.
    • FUJIFILM Holdings Corporation
    • Jiangsu Hengrui Pharmaceutical Co., Ltd.
    • Jodas Expoim Pvt. Ltd.
    • Shenzen Seacrown Electromechanical Co., Ltd.
    • Sino Medical-Device Technology Co., Ltd.
    • Unijules Life Sciences Ltd.
Product Code: BHR1815SS

“The Asia-Pacific Contrast Media Agent and Injector System Market Expected to Reach $2.62 Billion by 2026.”

Introduction to Asia-Pacific Contrast Media Agent and Injector System Market

The Asia-Pacific contrast media agent and injector system market was valued at $1.98 billion in 2022 and is expected to reach $2.62 billion by 2026, growing at a CAGR of 7.24% during the forecast period 2022-2026.The market is driven due to factors like rising cases of cancer and cardiovascular diseases, which result in higher demand for contrast media agents, injector systems, and image-guided diagnostic procedures.

KEY MARKET STATISTICS
Forecast Period2022 - 2026
2022 Evaluation$1.98 Billion
2026 Forecast$2.62 Billion
CAGR7.24%

Market Introduction

The APAC Contrast Media Agent and Injector System Market is witnessing substantial growth driven by several key factors. Firstly, the rising incidence of medical conditions such as cancer and cardiovascular diseases has led to an increased demand for imaging procedures that require contrast media agents and injector systems. This is particularly crucial for accurate diagnosis and treatment planning.

Secondly, advancements in medical imaging technologies have further fueled market growth. The development of innovative contrast media agents and injector systems has improved the precision and effectiveness of diagnostic procedures, making them more accessible and reliable for healthcare providers.

Lastly, the expanding healthcare infrastructure and increasing healthcare expenditure in the Asia-Pacific region have contributed to the market's expansion. As healthcare facilities continue to modernize and upgrade their imaging capabilities, the demand for contrast media agents and injector systems is expected to continue its upward trajectory in the region.

Market Segmentation:

Segmentation 1: by Product

  • Contrast Media Agents
  • Injector Systems

Segmentation: Injector Systems (by Product)

  • Injector
  • Consumables and Accessories

Segmentation 2: by Country

  • China
  • Japan
  • India
  • Australia
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Growth/Marketing Strategy: The APAC contrast media agent and injector system market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint ventures.

Competitive Strategy: The APAC contrast media agent and injector system market consists of various leading manufacturers, small-medium enterprises, and emerging startups. With the increasing demand for advanced devices, companies can expand their presence in the market through different strategic approaches. Some of the strategies followed by the leading contributors are the launch of new products, mergers and acquisitions, and regulatory and legal approvals.

Key Companies Profiled

  • Beijing Beilu Pharmaceutical Co. Ltd.
  • FUJIFILM Holdings Corporation
  • Jiangsu Hengrui Pharmaceutical Co., Ltd.
  • Jodas Expoim Pvt. Ltd.
  • Shenzen Seacrown Electromechanical Co., Ltd.
  • Sino Medical-Device Technology Co., Ltd.
  • Unijules Life Sciences Ltd.

Table of Contents

Executive Summary

Scope of the Study

Research Methodology

1. Markets

  • 1.1. Market Outlook
    • 1.1.1. Product Definition
    • 1.1.2. Inclusion and Exclusion Criteria
  • 1.2. Market Overview
  • 1.3. Industry Outlook
    • 1.3.1. Regulatory and Legal Requirements and Framework
      • 1.3.1.1. Regulatory and Legal Requirements and Framework in Asia-Pacific
        • 1.3.1.1.1. China
        • 1.3.1.1.2. Japan
    • 1.3.2. Patent Analysis
      • 1.3.2.1. Patent Filing Trend (by Year)
      • 1.3.2.2. Patent Filing Trend (by Country)
    • 1.3.3. Key Trends
      • 1.3.3.1. Nanoparticle-Based Contrast Agents
      • 1.3.3.2. Development of Safer Contrast Media Agent
      • 1.3.3.3. Partnerships and Business Alliances among Players for Strong Foothold in Different Regions
  • 1.4. Impact of COVID-19 on Contrast Media Agent and Injector System Market
    • 1.4.1. Pre-COVID-19 Impact
    • 1.4.2. During COVID-19 Impact
    • 1.4.3. Post-COVID-19 Impact
  • 1.5. Market Dynamics
    • 1.5.1. Impact Analysis
    • 1.5.2. Market Drivers
      • 1.5.2.1. Increasing Prevalence of Cancer and Cardiovascular Diseases Leading to Upsurge Demand of Imaging with Contrast Media Agents and Injector System
      • 1.5.2.2. Upsurge in Demand for Image-Guided Diagnostics
      • 1.5.2.3. Growing Number of Regulatory Approvals
    • 1.5.3. Market Restraints
      • 1.5.3.1. Rising Health Concerns Post Usage of Contrast Media Agents in Body
    • 1.5.4. Market Opportunities
      • 1.5.4.1. IT Advances in Contrast Media Injectors

2. Region

  • 2.1. Overview
  • 2.2. Asia-Pacific
    • 2.2.1. Key Findings
    • 2.2.2. Market Dynamics
      • 2.2.2.1. Impact Analysis
    • 2.2.3. Market Size and Forecast
      • 2.2.3.1. Asia-Pacific Contrast Media Agent and Injector System Market (by Product)
        • 2.2.3.1.1. Asia-Pacific Contrast Media Injector System Market (by Product)
      • 2.2.3.2. Asia-Pacific Contrast Media Agent and Injector System Market (by Country)
        • 2.2.3.2.1. China
          • 2.2.3.2.1.1. Market Sizing and Forecast
          • 2.2.3.2.1.1.1. China Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.1.1.1.1. China Contrast Media Injector System Market (by Product)
        • 2.2.3.2.2. Japan
          • 2.2.3.2.2.1. Market Sizing and Forecast
          • 2.2.3.2.2.1.1. Japan Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.2.1.1.1. Japan Contrast Media Injector System Market (by Product)
        • 2.2.3.2.3. India
          • 2.2.3.2.3.1. Market Sizing and Forecast
          • 2.2.3.2.3.1.1. India Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.3.1.1.1. India Contrast Media Injector System Market (by Product)
        • 2.2.3.2.4. Australia
          • 2.2.3.2.4.1. Market Sizing and Forecast
          • 2.2.3.2.4.1.1. Australia Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.4.1.1.1. Australia Contrast Media Injector System Market (by Product)
        • 2.2.3.2.5. Rest-of-Asia-Pacific
          • 2.2.3.2.5.1. Market Sizing and Forecast
          • 2.2.3.2.5.1.1. Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.5.1.1.1. Rest-of-Asia-Pacific Contrast Media Injector System Market (by Product)

3. Markets - Competitive Benchmarking & Company Profiles

  • 3.1. Competitive Benchmarking
    • 3.1.1. Key Strategies and Development
      • 3.1.1.1. Regulatory and Legal Activities
      • 3.1.1.2. Partnerships, Collaborations, and Business Expansions
      • 3.1.1.3. Mergers and Acquisitions
      • 3.1.1.4. New Offerings
    • 3.1.2. Market Share Analysis
      • 3.1.2.1. Market Share Analysis, by Contrast Media Agent Market
      • 3.1.2.2. Market Share Analysis, by Contrast Media Injector System Market
  • 3.2. Contrast Media Ecosystem Active Players
  • 3.3. Company Profiles
    • 3.3.1. Beijing Beilu Pharmaceutical Co. Ltd.
      • 3.3.1.1. Company Overview
      • 3.3.1.2. Role of Beijing Beilu Pharmaceutical Co. Ltd. in the Contrast Media Agent and Injector System Market
      • 3.3.1.3. Recent Developments
      • 3.3.1.4. Analyst Perception
    • 3.3.2. FUJIFILM Holdings Corporation
      • 3.3.2.1. Company Overview
      • 3.3.2.2. Role of FUJIFILM Holdings Corporation in the Contrast Media Agent and Injector System Market
      • 3.3.2.3. Financials
      • 3.3.2.4. Analyst Perception
    • 3.3.3. Jiangsu Hengrui Pharmaceutical Co., Ltd.
      • 3.3.3.1. Company Overview
      • 3.3.3.2. Role of Jiangsu Hengrui Pharmaceutical Co., Ltd. in the Contrast Media Agent and Injector System Market
      • 3.3.3.3. Recent Developments
      • 3.3.3.4. Analyst Perception
    • 3.3.4. Jodas Expoim Pvt. Ltd.
      • 3.3.4.1. Company Overview
      • 3.3.4.2. Role of Jodas Expoim Pvt. Ltd. in the Contrast Media Agent and Injector System Market
      • 3.3.4.3. Analyst Perception
    • 3.3.5. Shenzen Seacrown Electromechanical Co., Ltd.
      • 3.3.5.1. Company Overview
      • 3.3.5.2. Role of Shenzen Seacrown Electromechanical Co., Ltd. in the Contrast Media Agent and Injector System Market
      • 3.3.5.3. Recent Developments
      • 3.3.5.4. Analyst Perception
    • 3.3.6. Sino Medical-Device Technology Co., Ltd.
      • 3.3.6.1. Company Overview
      • 3.3.6.2. Role of Sino Medical-Device Technology Co., Ltd. in the Contrast Media Agent and Injector System Market
      • 3.3.6.3. Analyst Perception
    • 3.3.7. Unijules Life Sciences Ltd.
      • 3.3.7.1. Company Overview
      • 3.3.7.2. Role of Unijules Life Sciences Ltd. in the Contrast Media Agent and Injector System Market
      • 3.3.7.3. Analyst Perception

List of Figures

  • Figure 1: Asia-Pacific Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 2: Contrast Media Agent and Injector System Market, Impact Analysis
  • Figure 3: Asia-Pacific Contrast Media Agent and Injector System Market (by Product), $Million, 2021 and 2026
  • Figure 4: Contrast Media Agent and Injector System Market (by Region), $Million, 2021 and 2026
  • Figure 5: Contrast Media Agent and Injector System Market: Research Methodology
  • Figure 6: Primary Research Methodology
  • Figure 7: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 8: Top-Down Approach (Segment-Wise Analysis)
  • Figure 9: Contrast Media Agent and Injector System Market, Patent Analysis (by Year), January 2018-May 2022
  • Figure 10: Contrast Media Agent and Injector System Market, Patent Analysis (by Country), January 2018-May 2022
  • Figure 11: Number of CT Scans Per One Million Inhabitants in Asia-Pacific (by Country), 2015, 2017, and 2019
  • Figure 12: Contrast Media Agent and Injector System Market, Impact Analysis
  • Figure 13: Expected Number of Cancer Cases, Globally, 2020, 2025, 2030, 2035, and 2040
  • Figure 14: Incidence of Cardiovascular Disease, 2015 - 2019, Million
  • Figure 15: Innovative Vendors Product Solutions
  • Figure 16: Contrast Media Agent and Injector System Market (by Region), % Share, 2021-2026
  • Figure 17: Asia-Pacific Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 18: Asia-Pacific Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 19: Asia-Pacific Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 20: Asia-Pacific Contrast Media Agent and Injector System Market (by Country), % Share, 2021 and 2026
  • Figure 21: China Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 22: China Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 23: China Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 24: Japan Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 25: Japan Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 26: Japan Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 27: India Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 28: India Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 29: India Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 30: Australia Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 31: Australia Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 32: Australia Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 33: Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 34: Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 35: Rest-of-Asia-Pacific Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 36: Contrast Media Agent and Injector System Market, Number of Key Developments and Strategies, January 2018-May 2023
  • Figure 37: Regulatory and Legal Activities, January 2018-May 2023
  • Figure 38: Partnerships, Collaborations, and Business Expansions, January 2018-May 2023
  • Figure 39: Mergers and Acquisitions, January 2018-May 2023
  • Figure 40: New Offerings, January 2018-May 2023
  • Figure 41: Contrast Media Agent Market, Company Revenue Share Analysis, $Million, 2021
  • Figure 42: Contrast Media Injector System Market, Company Revenue Share Analysis, $Million, 2021
  • Figure 43: Beijing Beilu Pharmaceutical Co. Ltd.: Product Portfolio
  • Figure 44: FUJIFILM Holdings Corporation: Overall Product Portfolio
  • Figure 45: FUJIFILM Holdings Corporation: Overall Financials, $Million, 2020-2022
  • Figure 46: FUJIFILM Holdings Corporation: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 47: FUJIFILM Holdings Corporation: Net Revenue (by Region), $Million, 2020-2022
  • Figure 48: FUJIFILM Holdings Corporation: R&D Expenditure, $Million, 2020-2022
  • Figure 49: Jiangsu Hengrui Pharmaceutical Co., Ltd.: Product Portfolio
  • Figure 50: Jodas Expoim Pvt. Ltd.: Product Portfolio
  • Figure 51: Shenzen Seacrown Electromechanical Co., Ltd.: Product Portfolio
  • Figure 52: Sino Medical-Device Technology Co., Ltd.: Product Portfolio
  • Figure 53: Unijules Life Sciences Ltd.: Product Portfolio

List of Tables

  • Table 1: Contrast Media Agent and Injector System Market, Key Developments Analysis, January 2018-May 2023
  • Table 2: Key Questions Answered in the Report
  • Table 3: Contrast Media Agent and Injector System Market, Partnerships and Business Alliances, January 2018-May 2023
  • Table 4: Some of the Regulatory Approvals in Contrast Media Agent and Injector System Market, 2019-2023
  • Table 5: Some of the Contrast Media Reactions and Effects
  • Table 6: Guidelines for Contrast Administration and Hydration
  • Table 7: Asia-Pacific Contrast Media Agent and Injector System Market, Impact Analysis
  • Table 8: Contrast Media Ecosystem Active Players